Women's health discussion
forums, research news and
women's health issues.
DISCUSSION FORUMS...

Trying To Conceive

Surviving Miscarriage

Overcoming Infertility

Reproductive Health

General Health

Contraception

Pregnancy

Parenting

Babies and Toddlers

Relationships

Mental Health

Diet & Weight


ARTICLES ABOUT...

Relationships

Sexual Dysfunction

Looking Good

STDs

Men

Contraception

Reproductive Health

Conceiving

Pregnancy

Incontinence

Mental Health

Children's Health

Eating Well

Healthy Living

Supplements

Menopause

Weight Issues

Breast Cancer

Custom Search

5 April 2012
Anorexia successfully treated with antipsychotic drug

University of Chicago researchers say treating anorexia nervosa with low doses of a commonly used antipsychotic drug "consistently worked." Appearing in the journal Neuropsychopharmacology, the study offers promise for a common and sometimes fatal eating disorder that currently lacks approved drugs for treatment.

Researcher Stephanie Klenotich said that mice treated with small doses of the drug olanzapine (marketed as Zyprexa, Zydis or Relprevv) were more likely to maintain their weight when given an exercise wheel and restricted food access, conditions that produce activity-based anorexia (ABA) in animals. The antidepressant fluoxetine, commonly prescribed off-label for anorexic patients, did not improve survival in the experiment.

"We found over and over again that olanzapine was effective in harsher conditions, less harsh conditions, adolescents, adults - it consistently worked," Klenotich noted.

The study was the product of a rare collaboration between laboratory scientists and clinicians seeking new treatment options for anorexia nervosa. "Anorexia nervosa is the most deadly psychiatric disorder, and yet no approved pharmacological treatments exist," said co-researcher Stephanie Dulawa. "One wonders why there isn't more basic science work being done to better understand the mechanisms and to identify novel pharmacological treatments."

The new study offers support for the clinical use of olanzapine, for which clinical trials are already under way to test in patients. Co-researcher Daniel Le Grange said the development of a pharmacological variant that more selectively treats anorexia nervosa could be a helpful way to avoid the "stigma" of taking an antipsychotic while giving clinicians an additional tool for helping patients.

"I think the clinical field is certainly very ready for something that is going to make a difference," Le Grange said. "I'm not saying there's a 'magic pill' for anorexia nervosa, but we have been lacking any pharmacological agent that clearly contributes to the recovery of our patients. Many parents and many clinicians are looking for that, because it would make our job so much easier if there was something that could turn symptoms around and speed up recovery."

Related:
Discuss this article in our forum
Battle for the "real" self hints at new treatments for anorexia
Body dysmorphia sufferers have abnormal vision
Psychiatric disorders an ongoing issue after anorexia
MRI Reveals Anorexia Brain Damage

Source: University of Chicago Medical Center


Discussion Forums     About Us     Privacy
Your use of this website indicates your agreement to our terms of use.
2002 - 2013 Aphrodite Women's Health and its licensors. All rights reserved.